Why Crypto-Related Companies Traded Higher; Here Are 72 Biggest Movers From Yesterday
Today, 6:09 PM
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
This Financial Services Stock Is Trading Higher By 50%, Here Are 40 Stocks Moving In Tuesday’s Mid-Day Session
Today, 6:09 PM
Gainers
Applied Blockchain, Inc. (NASDAQ: APLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.
This Healthcare Stock Jumps Around 188%, Here’s 83 Biggest Movers From Yesterday
Today, 6:09 PM
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Why Is NeuroSense Therapeutics Surging by 70%? 46 Stocks Moving In Monday’s Mid-Day Session
Today, 6:09 PM
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Epizyme + 20 Stocks Moving In Monday’s Pre-Market Session
Today, 6:09 PM
Gainers
Tenax Therapeutics, Inc. (NASDAQ: TENX) rose 90.1% to $0.59 in pre-market trading after dipping more than 46% on Friday.
Carnival Surges Over 12%, Here’s 75 Biggest Movers From Friday
Today, 6:09 PM
Gainers
USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation solutions provider.
91 Biggest Movers From Friday
Today, 6:09 PM
Gainers
RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
44 Stocks Moving In Friday’s Mid-Day Session
Today, 6:09 PM
Gainers
Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ongoing Phase 2 APEX clinical trial.